DSTF Annual Meeting: Prediction Models and New Alternative Methods in Pharmacology and Toxicology
![DSTF logo. DSTF logo.](/images/event-images/DSTF.jpg)
Register here. The registration deadline is September 1, 2024.
Registration fee:
Members: 1200 DKK
Non-members: 1600 DKK
Early Career participants (submitting an abstract): 0 DKK
PROGRAM
MONDAY NOVEMBER 11TH
11.30-12.00: COFFEE
12.00-13.00: LUNCH
13.00-13.10: WELCOME: Anders A. Jensen, DSTF president
THEME 1: In silico predictions
SESSION 1: Chair: Jorid Birkelund Sørli
13.10-13.50: KEY NOTE: Eva Wedebye, Danish QSAR Database, National Food
Institute, Technical University of Denmark. Introduction to QSAR: New trends in
the regulation.
13.50-14.20: Jacob Ardenkjær-Skinnerup, Technical University of Denmark.
Chemicals and breast cancer: PPARγ measurements and QSAR development.
14.20-14.50: COFFEE
SESSION 2: Chair: Tomas Mow
14.50-15.20: Piet H. van der Graff, Certara, United Kingdom. Quantitative Systems Pharmacology to guide drug discovery, development, and regulatory decision making.
15.20-15.50: Jorid Birkelund Sørli, The National Research Centre for The Working Environment, Denmark. The role of NAMs in chemical regulation.
15.50-16.00: BREAK (COFFEE)
SESSION 3: EARLY CAREER SESSION: Chairs: Maria Wielsøe and Mikkel Vendelbo
16.00-17.00: Oral Presentations (selected from submitted abstracts)
17.05-19.00: Poster Session with Refreshments & Snacks
18.00-19.00: GENERAL ASSEMBLY FOR THE DSTF MEMBERS (agenda will be sent later)
19.00-22.00: DINNER DSTF ANNUAL MEETING 2024
TUESDAY NOVEMBER 12TH
THEME 2: In vitro predictive methods
SESSION 4: Chair: Mikkel Vendelbo
8.30-9.00: David Kristensen, Danish Headache Center, Rigshospitalet.
Development of a cell model for migraine.
9.00-9.30: Klaus Eyer, Department of Biomedicine, Aarhus University. Single cell-based models in studies of cytokine release and inflammation.
9.30-10.00: COFFEE
SESSION 5: Chair: Morten Fjorholt
10.00-10.30: Tore Stage, Department of Public Health, University of Southern Denmark. Regulation of drug metabolism in 3D primary human hepatocytes and humans.
10.30-11.00: Klaus Rytved, LEO Pharma. Navigating Early Drug Development with Predictive Toxicology.
11.00-11.10: BREAK (COFFEE)
THEME 3: Organoids & microphysiological systems
SESSION 6: Chairs: Tomas Mow and Anders Jensen
11.10-12.10: KEY NOTE: Thomas Hartung, Johns Hopkins University.
ToxAIcology – the now, the new and the next.
12.10-13.00: LUNCH
SESSION 7: Chairs: Tomas Mow and Anders Jensen
13.00-13.30: Christine Mummery, Department of Anatomy and Embryology, Leiden University. Cardiotoxicity, disease modelling and drug discovery using cardiomyocytes from human pluripotent stem cells.
13.30-14.00: Joshua Mark Brickman, Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW), University of Copenhagen. Enhancer priming as a mean to generating improved models for liver function from pluripotent stem cells.
14.00-14.30: Emma Börgeson, Department of Biomedicine, Aarhus University.
A Personalized Medicine Approach to Tackle Immunometabolism and Cardiometabolic Disease.
14.30-14.40: PRIZE ANNOUNCEMENT: BEST ORAL and POSTER PRESENTATION FROM EARLY CAREER SESSION
14.40-15.00: Thanks and Goodbye and coffee before departure (transport to railway station and airport)